DaVita (NYSE:DVA) Price Target Raised to $175.00 at Truist Financial

DaVita (NYSE:DVA) had its price objective lifted by Truist Financial from $165.00 to $175.00 in a research note published on Monday morning, Benzinga reports. The firm currently has a hold rating on the stock.

Other research analysts have also issued research reports about the company. UBS Group boosted their target price on DaVita from $169.00 to $175.00 and gave the company a buy rating in a research report on Thursday, August 8th. TD Cowen increased their target price on DaVita from $139.00 to $150.00 and gave the stock a hold rating in a research note on Wednesday, July 24th. Finally, Bank of America boosted their target price on shares of DaVita from $139.00 to $145.00 and gave the company an underperform rating in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of Hold and an average price target of $159.00.

DaVita Price Performance

Shares of DaVita stock opened at $159.47 on Monday. The stock has a 50 day moving average price of $153.76 and a 200-day moving average price of $143.49. DaVita has a one year low of $71.51 and a one year high of $166.04. The stock has a market cap of $13.38 billion, a price-to-earnings ratio of 16.98, a price-to-earnings-growth ratio of 0.91 and a beta of 0.87. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, topping the consensus estimate of $2.47 by $0.12. The company had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. DaVita’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.08 earnings per share. Equities analysts expect that DaVita will post 9.99 EPS for the current year.

Insider Activity

In related news, insider Kathleen Alyce Waters sold 7,857 shares of the company’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total value of $1,148,771.97. Following the completion of the sale, the insider now directly owns 83,011 shares of the company’s stock, valued at $12,137,038.31. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the sale, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Michael David Staffieri sold 9,539 shares of DaVita stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total value of $1,431,136.17. Following the completion of the transaction, the chief operating officer now owns 241,945 shares in the company, valued at $36,299,008.35. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,482 shares of company stock worth $27,387,069. Company insiders own 2.00% of the company’s stock.

Hedge Funds Weigh In On DaVita

Large investors have recently made changes to their positions in the business. SG Americas Securities LLC grew its stake in DaVita by 196.9% during the 1st quarter. SG Americas Securities LLC now owns 29,733 shares of the company’s stock worth $4,105,000 after buying an additional 19,719 shares during the last quarter. Bessemer Group Inc. increased its holdings in shares of DaVita by 2,335.6% during the first quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock valued at $1,483,000 after acquiring an additional 10,300 shares in the last quarter. Forsta AP Fonden boosted its stake in DaVita by 50.3% in the 1st quarter. Forsta AP Fonden now owns 23,600 shares of the company’s stock worth $3,258,000 after purchasing an additional 7,900 shares in the last quarter. Fox Hill Wealth Management grew its position in DaVita by 138.4% during the 1st quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock worth $2,172,000 after purchasing an additional 9,135 shares during the last quarter. Finally, Sei Investments Co. grew its position in DaVita by 21.3% during the 1st quarter. Sei Investments Co. now owns 41,952 shares of the company’s stock worth $5,790,000 after purchasing an additional 7,371 shares during the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.